FILE- In this Aug. 9, 2018, file photo the logo for Rite Aid is displayed above a trading post on the floor of the New York Stock Exchange. Rite Aid, like larger rivals Walgreens Boots Alliance and CVS Health, is seeing smaller profits from the sale of generic drugs. Those pressures impacted fiscal fourth quarter earnings with Rite Aid Thursday reporting a $255.6 million loss from continuing operations in the period ended March 2. Rite Aid also Thursday disclosed plans to start selling CBD creams, lotions and lip balms as part of a pilot program in Oregon and Washington where it has about 200 stores. Rite Aid has 2,469 stores in 19 states, but most are concentrated in 7 states including California on the West Coast and Pennsylvania on the East Coast.

Source: Forbes April 11, 2019 13:28 UTC